QQQ   352.01 (+1.16%)
AAPL   180.09 (+1.60%)
MSFT   332.58 (+1.28%)
META   272.61 (+2.98%)
GOOGL   123.72 (+0.69%)
AMZN   122.77 (+1.82%)
TSLA   207.52 (+1.76%)
NVDA   397.70 (+5.12%)
NIO   7.54 (+0.13%)
BABA   83.00 (+4.34%)
AMD   119.47 (+1.07%)
T   15.81 (+0.51%)
F   12.11 (+0.92%)
MU   69.09 (+1.30%)
CGC   0.83 (-0.01%)
GE   104.67 (+3.09%)
DIS   88.59 (+0.72%)
AMC   4.55 (+1.11%)
PFE   38.02 (+0.00%)
PYPL   63.05 (+1.71%)
NFLX   403.13 (+2.00%)
QQQ   352.01 (+1.16%)
AAPL   180.09 (+1.60%)
MSFT   332.58 (+1.28%)
META   272.61 (+2.98%)
GOOGL   123.72 (+0.69%)
AMZN   122.77 (+1.82%)
TSLA   207.52 (+1.76%)
NVDA   397.70 (+5.12%)
NIO   7.54 (+0.13%)
BABA   83.00 (+4.34%)
AMD   119.47 (+1.07%)
T   15.81 (+0.51%)
F   12.11 (+0.92%)
MU   69.09 (+1.30%)
CGC   0.83 (-0.01%)
GE   104.67 (+3.09%)
DIS   88.59 (+0.72%)
AMC   4.55 (+1.11%)
PFE   38.02 (+0.00%)
PYPL   63.05 (+1.71%)
NFLX   403.13 (+2.00%)
QQQ   352.01 (+1.16%)
AAPL   180.09 (+1.60%)
MSFT   332.58 (+1.28%)
META   272.61 (+2.98%)
GOOGL   123.72 (+0.69%)
AMZN   122.77 (+1.82%)
TSLA   207.52 (+1.76%)
NVDA   397.70 (+5.12%)
NIO   7.54 (+0.13%)
BABA   83.00 (+4.34%)
AMD   119.47 (+1.07%)
T   15.81 (+0.51%)
F   12.11 (+0.92%)
MU   69.09 (+1.30%)
CGC   0.83 (-0.01%)
GE   104.67 (+3.09%)
DIS   88.59 (+0.72%)
AMC   4.55 (+1.11%)
PFE   38.02 (+0.00%)
PYPL   63.05 (+1.71%)
NFLX   403.13 (+2.00%)
QQQ   352.01 (+1.16%)
AAPL   180.09 (+1.60%)
MSFT   332.58 (+1.28%)
META   272.61 (+2.98%)
GOOGL   123.72 (+0.69%)
AMZN   122.77 (+1.82%)
TSLA   207.52 (+1.76%)
NVDA   397.70 (+5.12%)
NIO   7.54 (+0.13%)
BABA   83.00 (+4.34%)
AMD   119.47 (+1.07%)
T   15.81 (+0.51%)
F   12.11 (+0.92%)
MU   69.09 (+1.30%)
CGC   0.83 (-0.01%)
GE   104.67 (+3.09%)
DIS   88.59 (+0.72%)
AMC   4.55 (+1.11%)
PFE   38.02 (+0.00%)
PYPL   63.05 (+1.71%)
NFLX   403.13 (+2.00%)
TSE:I

Intellipharmaceutics International (I) Competitors

Compare
Today's Range
N/A
50-Day Range
C$3.23
▼
C$3.23
52-Week Range
N/A
Volume
7,625 shs
Average Volume
16,872 shs
Market Capitalization
C$97.40 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ProfileChartCompetitorsEarningsInsider TradesHeadlinesOptions ChainSocial Media

I vs. BRAG, EGLX, FORA, IDG, CHW, SPN, CWL, MBA, PKT, and NLN

Should you be buying Intellipharmaceutics International stock or one of its competitors? The main competitors of Intellipharmaceutics International include Bragg Gaming Group (BRAG), Enthusiast Gaming (EGLX), VerticalScope (FORA), Indigo Books & Music (IDG), Chesswood Group (CHW), Snipp Interactive (SPN), Caldwell Partners International (CWL), CIBT Education Group (MBA), Parkit Enterprise (PKT), and NeuLion (NLN). These companies are all part of the "business services" sector.

Intellipharmaceutics International vs.

Intellipharmaceutics International (TSE:I) and Bragg Gaming Group (TSE:BRAG) are both small-cap business services companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, profitability, valuation, analyst recommendations, media sentiment, community ranking, risk, institutional ownership and dividends.

In the previous week, Intellipharmaceutics International's average media sentiment score of 0.00 equaled Bragg Gaming Group's average media sentiment score.

Company Overall Sentiment
Intellipharmaceutics International Neutral
Bragg Gaming Group Neutral

Intellipharmaceutics International has a net margin of 0.00% compared to Bragg Gaming Group's net margin of -3.67%. Intellipharmaceutics International's return on equity of 0.00% beat Bragg Gaming Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Intellipharmaceutics International N/A N/A N/A
Bragg Gaming Group -3.67% -4.69% -0.29%

Intellipharmaceutics International has higher earnings, but lower revenue than Bragg Gaming Group.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Intellipharmaceutics InternationalN/AN/AN/AN/AN/A
Bragg Gaming GroupC$88.23 million1.09-C$3.24 million-C$0.20-22.40

Bragg Gaming Group has a consensus price target of C$11.75, suggesting a potential upside of 162.28%.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Intellipharmaceutics International
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Bragg Gaming Group
0 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
3.00

7.0% of Bragg Gaming Group shares are owned by institutional investors. 23.9% of Bragg Gaming Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Intellipharmaceutics International received 77 more outperform votes than Bragg Gaming Group when rated by MarketBeat users. Likewise, 66.94% of users gave Intellipharmaceutics International an outperform vote while only 66.67% of users gave Bragg Gaming Group an outperform vote.

CompanyUnderperformOutperform
Intellipharmaceutics InternationalOutperform Votes
83
66.94%
Underperform Votes
41
33.06%
Bragg Gaming GroupOutperform Votes
6
66.67%
Underperform Votes
3
33.33%

Summary

Intellipharmaceutics International beats Bragg Gaming Group on 5 of the 9 factors compared between the two stocks.


New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding I and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

I vs. The Competition

Export to Excel
MetricIntellipharmaceutics InternationalWireless Telecommunications IndustryBusiness SectorTSE Exchange
Market CapC$97.40MN/AC$4.84BC$4.51B
Dividend YieldN/A6.28%4.85%5.04%
P/E RatioN/A1.19285.7722.98
Price / SalesN/AN/A336.251,334.08
Price / CashN/AN/A234.0678.71
Price / BookN/AN/A5.553.58
Net IncomeN/AN/AC$118.08MC$334.32M

Intellipharmaceutics International Competitors List

Export to Excel
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BRAG
Bragg Gaming Group
0 of 5 stars		C$4.50
-0.9%		C$11.75
+161.1%		-31.2%C$96.98MC$88.23M-22.50N/A
EGLX
Enthusiast Gaming
0 of 5 stars		C$0.63
-1.6%		C$4.00
+534.9%		-81.3%C$95.62MC$198.55M-1.21N/APositive News
FORA
VerticalScope
1.6007 of 5 stars		C$3.77
+4.7%		C$8.33
+121.0%		-79.3%C$68.95MC$80.49M-2.73N/AGap Up
IDG
Indigo Books & Music
0 of 5 stars		C$2.00
-0.5%		C$4.30
+115.0%		-46.8%C$54.70MC$1.08B-1.835,000News Coverage
CHW
Chesswood Group
2.2778 of 5 stars		C$8.09
-0.7%		C$13.58
+67.9%		-40.7%C$156.14MC$158.67M5.62299
SPN
Snipp Interactive
0 of 5 stars		C$0.12
+9.1%		N/A-19.4%C$33.88MC$21.89M12.005,200
CWL
Caldwell Partners International
0 of 5 stars		C$1.11
flat		N/A-53.9%C$28.73MC$122.58M4.44131
MBA
CIBT Education Group
0 of 5 stars		C$0.40
+5.3%		C$1.42
+255.0%		-25.5%C$27.01MC$74.49M-1.54358Gap Up
PKT
Parkit Enterprise
0 of 5 stars		C$0.82
-6.8%		C$1.10
+34.1%		-22.7%C$191.75MC$11.27M-82.00N/AGap Down
NLN
NeuLion
0 of 5 stars		N/AN/AN/AC$302.76MN/A0.00147,000High Trading Volume

Related Companies and Tools

Related Companies:
Top 10 Stock Comparisons
This page (TSE:I) was last updated on 6/1/2023 by MarketBeat.com Staff

My Account -